Skin and Mucosal Delivery (Focus Group – SMD)
Carles Prado Morales
PhD Candidate
IBEC
Barcelona, Spain
The skin is the body’s primary biological barrier.1 Although essential for protection, this barrier function limits the efficacy of transdermal drug delivery, as most topically applied compounds fail to reach deeper skin layers at therapeutically relevant concentrations.2 Existing approaches often rely on physical disruption of the barrier, which can cause undesirable side effects.3 Moreover, many prior studies have been conducted in murine models, which do not accurately recapitulate human skin physiology, hindering the translation to humans.4 Here, we present an alternative approach using enzymatically powered nanomotors tested in a human reconstructed skin model.